Open Your FREE Demat Account Now!

Decipher Labs Ltd. Share Price

NSE
BSE

BSE : 524752

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹5.60
Day's Range ₹5.55 - ₹5.95
Open ₹5.55
52 Week Range ₹05.00 - ₹10.99
Volume 5,032
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 0.28
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 0.00
TTM EPS (₹) -3.03
P/E Ratio 0.00
Book Value(₹) 0.31
PAT Margin (%) -22.47
Face Value (₹) 10.00
ROCE(%) -28.39

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 29.24 226.12
Expenses N/A N/A
PBT -34.22 -63.86
Operating profit 0.0 0.0
Net profit -34.27 -50.8

Shareholding Pattern

Promoters (% Holding)

16.43%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

83.57%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Decipher Labs Ltd.

Founded 1986

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,32,120.23 1,801.00 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,53,389.76 9,545.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,81,739.76 4,778.00 3,480.60 - 3,480.60
Lenskart Solutions Ltd. 1,19,116.38 682.95 0.00 - 0.00
Zydus Lifesciences Ltd. 1,15,710.44 1,160.00 835.50 - 835.50
Apollo Hospitals Enterprise Ltd. 1,13,733.66 7,910.00 6,696.50 - 6,696.50
Laurus Labs Ltd. 1,10,980.13 2,054.00 843.00 - 843.00
Cipla Ltd. 1,08,497.02 1,343.00 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,02,649.97 2,485.20 1,909.70 - 1,909.70
Dr. Reddy's Laboratories Ltd. 1,00,925.37 1,209.15 1,101.00 - 1,101.00
no-content No Records Found

Latest News

Sep
29
2026
EQUITY Posted on Sep 29th 2026

Decipher Labs informs about closure of trading window

Pursuant to the Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, Decipher Labs has informed that the trading window for dealing in the securities of the Company will remain closed from 01.10.2026 till 48 hours after the declaration of un audited financial results for the quarter and half year ending 30.09.2026, for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for the declaration of financial results of the Company for the quarter and half year ending 30.09.2026 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Alembic Pharmaceuticals informs about certificate

Alembic Pharmaceuticals has informed that it enclosed a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2026 received from MUFG lntime India (Formerly known as Link lntime India), Registrar and Share Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Cohance Lifesciences informs about ESG rating

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026, Cohance Lifesciences has informed that Crisil ESG Ratings & Analytics (Crisil ESG Ratings) has voluntarily assigned an ESG Rating of ‘Crisil ESG 61 (Strong)’ and Core ESG Rating of ‘Crisil Core ESG 67 (Strong)’ to the Company. The link for the rating as published by Crisil ESG Ratings: https://www.crisilesg.com/en/home/esg-ratings.html. The Company has not engaged Crisil ESG Ratings for the ESG Rating. The rating has been independently determined by Crisil ESG Ratings based on publicly available information pertaining to the Company. 

The above information is a part of company’s filings submitted to BSE. 

Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Bliss GVS Pharma informs about certificate

Bliss GVS Pharma has informed that it enclosed a certificate received from MUFG Intime India (Formerly known as Link Intime India), Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026. 
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Artemis Medicare Services informs about compliance certificate

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Artemis Medicare Services has informed that the Certificate for the quarter ended September 30, 2026 is enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Decipher Labs Ltd. ?

The current share price of Decipher Labs Ltd. is ₹5.60 as of 2026-10-06.

The market capitalisation of Decipher Labs Ltd. is ₹5.66 as of 2026-10-06.

The 1-year return of Decipher Labs Ltd. is -4.53% as of 2026-10-06.

The P/E ratio of Decipher Labs Ltd. is 0.00 as of 2026-10-07.

The 52-week high and low of Decipher Labs Ltd. are ₹10.99 and ₹5.00, respectively, as of 2026-10-06.

The dividend yield of Decipher Labs Ltd. is 0.0% as of2026-10-06.

You can buy Decipher Labs Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Decipher Labs Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore